Surveillance data show summer 2022 increases in pediatric acute respiratory illness and asthma

A surveillance report from the United States described patterns of acute respiratory illness and asthma or reactive airway disease in children and adolescents during summer 2022. The report indicated an increase in these conditions, but did not report on specific exposures, interventions, comparators, or the sample size. No effect sizes, absolute numbers, p-values, or confidence intervals were provided for the reported increases. The report did not include information on safety, tolerability, adverse events, or follow-up duration. Key limitations include the observational nature of surveillance data, which can only show association and not causation. The lack of reported effect sizes, population denominators, and specific exposures limits interpretation of the findings. For clinicians, this report serves as a signal of increased pediatric respiratory morbidity during a specific period, but the data are insufficient to guide specific clinical actions or infer causes.